Herschler Building East 2nd Floor
122 W 25th St, Cheyenne, WY 82002
Phone: (307) 634-9636 Fax: (307) 634-6335
bop@wyo.gov

Mission Statement

The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.

License Verification

Prescription Drug Monitoring Program

Current News & Information

2026 Wyoming Pharmacist and Pharmacy Technician Renewals

The Board’s Online Portal has been updated. Renewal notices have been emailed to the email address on file with the Board. Pharmacists and technicians will need to create new user accounts on the portal to renew their license. The portal is available at:

https://wybopv7prod.glsuite.us/ui/licenseelogin/Login

To create an account, pharmacists and technicians will need to click on “Sign up now” and follow the prompts. The verification code will come from Microsoft on behalf of the Wyoming State Board of Pharmacy. Depending on your email settings, it may get filtered into your Spam or Junk folder. When entering their name, pharmacists/pharmacy technicians will need to enter their first and last name as it appears on their license.

As a reminder, for their 2026 license renewal:

Pharmacists must complete 15 hours of ACPE-accredited continuing education, including 1.5 hours related to responsible prescribing of controlled substances. Any CE activity that is coded to ACPE topic “8” will meet this requirement.
Pharmacy technicians must complete 10 hours of ACPE-accredited continuing education.
Pharmacists and pharmacy technicians who immunize must complete 1 hour of CE related to immunizations.
ALL CE must be ACPE-accredited* and be reported to NABP’s CPE Monitor.

Certification or recertification of CPR, ACLS, or PALS by the American Red Cross or the American Heart Association is no longer recognized as acceptable CE unless the course is ACPE-accredited. Separate immunization and/or preceptor registrations are no longer required.

*A statement of credit is not proof of completion. The Wyoming Pharmacy Act Chapter 6: Continuing Professional Education Regulations requires pharmacists and pharmacy technicians to have their CPE reported into NABP's CPE monitor. ACPE’s policy also states that CPE Monitor is the official place of record.

Revisions to the Wyoming Pharmacy Act Rules and Regulations, Chapter 22: Compounding, Approved by Governor Gordon

The revisions to Chapter 22: Compounding, have been approved by Governor Gordon. The chapter is publicly available on the Board's website at https://pharmacyboard.wyo.gov/laws, and the Wyoming Secretary of State's website at https://rules.wyo.gov.

Proposed Revisions to Wyoming Controlled Substances Act Rules & Regulations – Chapter 8: Prescription Drug Monitoring Program

The Wyoming State Board of Pharmacy proposes to amend Chapter 8: Prescription Drug Monitoring Program, of the Wyoming Controlled Substances Act Rules and Regulations to simplify data retention in the controlled substance prescription tracking program.

As required by Wyoming Statute § 16-3-103(a)(i)(G), these rules meet minimum substantive state statutory requirements.

Chapter 8: Prescription Drug Monitoring Program

Section 8(c) is revised so that records shall be maintained in the database for five (5) years. Currently, records that are older than five (5) years, are deidentified and archived for research purposes. Deidentification removes information so that the dispensing data cannot be associated with an individual patient. This process removes most of the data’s research value and cannot be undone. Storing data indefinitely will increase the database’s costs. The proposed revision will help to keep the database’s costs low and aligns with the Chapter’s other data retention requirements, e.g. records of solicited and unsolicited patient reports which are kept for five (5) years.

The proposed revisions also include minor grammatical/non-substantive changes:

Bringing the chapter name below the chapter number to match the formatting requested by the Secretary of State’s office;
Adding a missing period to the sentence in section 2; and
Adding an apostrophe in Section 5(a)(ix)

Requests for copies of the proposed revisions may be addressed to the Board executive director at 122 West 25th Street, Herschler Building East 2nd Floor, Cheyenne, WY 82002. The proposed revisions are posted on the Wyoming Secretary of State and the Wyoming State Board of Pharmacy websites. Comments may be submitted to the Board by mail using the address above or to bop@wyo.gov on or before October 16, 2026, at 5 PM MDT.

Alerts & Other Information

Twelfth PREP Act Declaration extends
COVID-19 Countermeasures through
December 2029

PREP Act immunity from liability was extended by HHS through through the final day of the applicable Declaration of Emergency, or December 2029 to pharmacists, pharmacy interns, and pharmacy technicians to administer COVID-19 and seasonal influenza vaccines (to those individuals three and over, consistent with other requirements), and COVID-19 tests, regardless of any USG agreement or emergency declaration. For additional information:

REMINDER ALERT

Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition Fraud Alert

The Board's September 2022 newsletter had an article on the Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition's fraud alert that outlines some new methodologies that are being used to divert both small and large drug shipments. These schemes may involve the impersonation of regulatory personnel, including individuals from state boards of pharmacy and departments of health. They may also involve the impersonation of pharmacy or distributor staff.

Last week a pharmacy in Casper reported being contacted by a scammer posing as the Wyoming Board of Pharmacy, who tried to obtain their wholesale distributor account number. In 2022, a pharmacy in Rock Springs, WY, reported being contacted by a scammer posing as their distributor, who said that they had shipped product to the pharmacy in error and requested that the shipment be returned.

More information is available from the National Association of Boards of Pharmacy®. If you experience an attempt at this type of scam, please email cforsaith@hda.org so that it can be shared with law enforcement.

ALERT Phishing Scam

The Board office has received reports that pharmacists are receiving calls that appear to come from the Board office’s main phone number and that the caller identifies himself or herself as an agent with the Board. The caller is able to confirm some of the pharmacist’s information, such as license number, National Provider Identifier number, and place of employment.

In some cases, the caller accuses the pharmacist of having committed a violation, that his or her license may be suspended or revoked, and that the pharmacist will be arrested if he or she does not answer the caller’s questions. In some cases, the caller alleges that the pharmacist was involved in prescription drug trafficking. Some pharmacists have reported that the caller becomes aggressive and demanding, threatening to have the Federal Bureau of Investigation come and arrest the pharmacist if he or she does not comply.

The Wyoming State Board of Pharmacy will not contact or interact with you in this manner.

The Federal Trade Commission has useful consumer information on how to recognize and avoid phishing scams available at https://www.consumer.ftc.gov/articles/how-recognize-and-avoid-phishing-scams. If you receive such a phone call, please call and report it to the Federal Communications Commission at 888/225- 5322.

DEA Warns Healthcare Workers of Impersonation Scam Targeting Doctors and Pharmacists

The Drug Enforcement Administration (DEA) issued a critical alert to healthcare professionals, warning of recent scam calls targeting doctors and pharmacists. Fraudsters are impersonating DEA agents to steal sensitive information and possibly extort money.

DEA personnel will never contact medical practitioners or members of the public by telephone to request personal or sensitive information, demand money or any other form of payment. Legitimate DEA agents will only notify individuals of investigations or legal actions in person or via official letter.

Reported scam tactics continually change but often share many of the same characteristics. Callers use names found online of well-known DEA officials, retired or former Special Agents, and/or police officers in local departments. Callers will also provide fake badge numbers. Additionally, they may:

use an urgent and aggressive tone.
threaten arrest, prosecution, imprisonment, and, in the case of medical practitioners and pharmacists, revocation of their DEA registration.
reference National Provider Identifier numbers and/or state license numbers when calling a medical practitioner. They also may claim that patients are making accusations against the practitioner.
ask for personal information, such as social security number or date of birth.

Protecting Against Identity Theft

The best deterrence against these bad actors is awareness and caution. Anyone receiving a call from a person claiming to be with DEA should report the incident to the FBI at www.ic3.gov. The Federal Trade Commission provides recovery steps, shares information with more than 3,000 law enforcement agencies and takes reports at reportfraud.ftc.gov.

Reporting these scam calls will help federal authorities find, arrest, and stop the criminals engaged in this fraud. Impersonating a federal agent is a violation of federal law, punishable by up to three years in prison; aggravated identity theft carries a mandatory minimum sentence of two years in prison plus fines and restitution.

The DEA is committed to protecting healthcare professionals from these fraudulent schemes. By raising awareness and encouraging prompt reporting, we can help to stop these criminals and ensure the safety and security of our nation's healthcare workforce.

ALERT Fraudulent Prescription SCAM

The Board has received alerts from pharmacies that an individual or group of individuals are calling in prescriptions for Azithromycin, Ibuprofen, and Promethazine with Codeine. Most of the calls have allegedly come from practitioners in Washington. In some instances, they are asking for particular manufacturers of Promethazine with Codeine, attempting to call multiple sets of prescriptions in at one time, and have requested the pharmacy to ship into another state. The Board urges pharmacists to be cautious and to utilize their professional judgment when exercising their corresponding responsibility and to carefully evaluate such prescriptions for validity before dispensing.

Report abuse